This Washington DC Lymphoma Rounds provides a forum for local practicing physicians from academic and community medical centers to meet on a regular basis and address issues specific to the diagnosis and treatment of their lymphoma patients. Physicians share best practices and learn the latest information on new therapies and advances in the management of lymphoma through interactive case studies presented by lymphoma experts in the local area. Please note that this program is only open to practicing lymphoma physicians and industry supporters. Please continue to check this page for updates. For updates, please ensure you are subscribed to receive emails from the Lymphoma Research Foundation
Full Lymphoma Rounds COVID policy (updated 06.30.2023) can be accessed here and required for review prior to submitting a registration.
Lymphoma Rounds: Washington DC
DATE: Thursday, November 30, 2023
TIME: Networking 6:00 PM – 7:00 PM ET
Program 7:00 PM – 8:30 PM ET
LOCATION: Le Meridien Arlington
1121 19th St North
Arlington, VA 22209
This program is free for healthcare professionals; however, pre-registration is required.
Please note: Only representatives from supporting pharmaceutical companies are invited to register. If your company is interested in becoming a Lymphoma Rounds supporter please contact Eva Migliore, LRF, at emigliore@lymphoma.org. Exhibit opportunities are available.
Companies that have secured a national exhibit sponsorship for Lymphoma Rounds must still rsvp by emailing Eva Migliore (emigliore@lymphoma.org) at least one week before the program to confirm their attendance.
PROGRAM AGENDA – TBA
ABOUT THE PROGRAM
The Lymphoma Rounds program provides a forum for local practicing physicians from academic and community medical centers to meet on a regular basis and address issues specific to the diagnosis and treatment of their lymphoma patients. Physicians share best practices and learn the latest information on new therapies and advances in the management of lymphoma through interactive case studies presented by lymphoma experts in the local area.
At the conclusion of this educational activity, the participant should be better able to:
- Summarize the latest developments in lymphoma diagnosis, treatment and management.
- Apply best practices for treating lymphoma patients.
- Inform patients about potential clinical trial opportunities.
- Establish a network of health care professionals who work with lymphoma patients.
This is the first program in the 2023-24 Washington DC Rounds series.
Washington DC Lymphoma Rounds Steering Committee
MedStar Georgetown University Hospital
Kieron Dunleavy, MD (chair)
Children’s National
Birte Wistinghausen, MD
MedStar Washington Hospital Center
Aarthi Shenoy, MD
National Cancer Institute/NIH
Mark Roschewski, MD
Rahul Lakhotia, MD
University of Virginia Cancer Center
Craig Portell, MD
Virginia Commonwealth University
Victor Yazbeck, MD
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and Lymphoma Research Foundation. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Statement
Penn State College of Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provided by:
Lymphoma Research Foundation and the Penn State College of Medicine
This activity is supported by educational grants from:
AbbVie, Inc., Acrotech, Adaptive Biotechnologies Corporation, ADC Therapeutics, AstraZeneca, BeiGene, Bristol Myers Squibb, BTG International Inc., Genmab, Kite Pharma Inc., Kyowa Kirin, Lilly USA, MorphoSys, Pharmacyclics LLC, an AbbVie Company / Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Seagen
